Ella Jeffries / beckershospitalreview - An implanted radiation device has improved tumor control and overall survival compared with standard radiation therapy in patients with newly diagnosed operable brain metastases, according to phase 3 clinical trial data presented May 30 at the American So…
AI Summary: Clinical trial data show an implanted "tile" radiation device placed at resection sites lowers local recurrence risk for patients with brain metastases. The approach provides a targeted, intraoperative boost that shortens treatment timelines — and gives surgeons one more tool to argue they cured something before the tumor disagreed.
SBRT extends progression‑free survival in oligometastatic breast cancer / 19 days
Ultra‑sensitive ctDNA blood test could personalize breast cancer care for older women / 2 months
First‑in‑human IL‑2 cytokine factory trial shows early promise in ovarian cancer / 21 days
Personalized glioblastoma vaccine shows early promise in trials / 23 days
High‑dose targeted radiation shows promise for huge bile duct tumors / 2 months
Two high‑dose radiotherapy sessions safely treat localized prostate cancer / 17 days
ESMO issues new metastatic colorectal cancer clinical guideline / 7 wks
StackHealth RSS


StackHealth Time Machine
NorthFeed Inc. Terms and Conditions / Privacy Policy
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.